Gilberto Rodrigues
Universidade de São Paulo, Instituto do Câncer do Estado de São Paulo
Papers
5
Total Citations
108
H-Index
4
About
Gilberto Rodrigues is a leading urologic surgeon and clinical researcher whose work has helped define the modern, evidence-based approach to minimally invasive cancer surgery. His primary research areas include the comparative effectiveness of robotic versus open surgery for prostate and kidney cancers, as well as the expansion of robotic techniques to complex oncologic procedures. Rodrigues’s most impactful contribution is his landmark 2024 randomized clinical trial comparing robot-assisted laparoscopic prostatectomy (RALP) to open radical retropubic prostatectomy, which has already garnered 47 citations for providing high-quality data on perioperative, oncological, and functional outcomes. He further strengthened the evidence base for minimally invasive surgery with a prospective, randomized trial on laparoscopic partial nephrectomy (30 citations), demonstrating its benefits for renal tumors. Beyond these core contributions, Rodrigues has advanced the field through narrative reviews and technical reports on robot-assisted retroperitoneal lymphadenectomy for testicular cancer and endoscopic inguinal lymphadenectomy for penile cancer, establishing himself as a key voice in the robotic management of urologic malignancies. His work is essential reading for any surgeon or researcher seeking rigorous clinical evidence to guide the adoption of robotic techniques.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3Robot-assisted retroperitoneal lymphadenectomy: The state of art18 citations · 2020
- 4
- 5